Literature DB >> 8772178

Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.

M Gschwendt1, S Dieterich, J Rennecke, W Kittstein, H J Mueller, F J Johannes.   

Abstract

Various inhibitors were tested for their potential to suppress the kinase activity of protein kinase C mu (PKC mu) in vitro and in vivo. Among the staurosporine-derived, rather selective PKC inhibitors the indolocarbazole Gö 6976 previously shown to inhibit preferentially cPKC isotypes proved to be a potent inhibitor of PKC mu with an IC50 of 20 nM, whereas the bisindolylmaleimide Gö 6983 was extremely ineffective in suppressing PKC mu kinase activity with a thousand-fold higher IC50 of 20 microM. Other strong inhibitors of PKC mu were the rather unspecific inhibitors staurosporine and K252a. Contrary to the poor inhibition of PKC mu by Gö 6983, this compound was found to suppress in vitro kinase activity of PKC isoenzymes from all three subgroups very effectively with IC50 values from 7 to 60 nM. Thus, Gö 6983 was able to differentiate between PKC mu and other PKC isoenzymes being useful for selective determination of PKC mu kinase activity in the presence of other PKC isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772178     DOI: 10.1016/0014-5793(96)00785-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  205 in total

1.  Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion.

Authors:  A Davy; N W Gale; E W Murray; R A Klinghoffer; P Soriano; C Feuerstein; S M Robbins
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

Review 2.  Molecular biology of protein kinase C signaling in cardiac myocytes.

Authors:  A Malhotra; B P Kang; D Opawumi; W Belizaire; L G Meggs
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

3.  Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.

Authors:  Yuri V Fedorov; Nathan C Jones; Bradley B Olwin
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 4.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

5.  Phosphorylation of threonine 154 in p40phox is an important physiological signal for activation of the neutrophil NADPH oxidase.

Authors:  Tamara A M Chessa; Karen E Anderson; Yanhua Hu; Qingbo Xu; Oliver Rausch; Len R Stephens; Phillip T Hawkins
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

6.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.

Authors:  Hatim A Hassan; Ming Cheng; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

7.  Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia.

Authors:  Bradley R Webster; Jessica M Osmond; Daniel A Paredes; Xavier A DeLeon; Olan Jackson-Weaver; Benjimen R Walker; Nancy L Kanagy
Journal:  J Pharmacol Exp Ther       Date:  2012-10-23       Impact factor: 4.030

8.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2016-03-05       Impact factor: 5.858

9.  Atypical protein kinase Cλ is critical for growth factor receptor-induced dorsal ruffle turnover and cell migration.

Authors:  Bowen Xing; Limin Wang; Dagang Guo; Jianyun Huang; Cedric Espenel; Geri Kreitzer; J Jillian Zhang; Lin Guo; Xin-Yun Huang
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

10.  Redox regulation of interleukin-4 signaling.

Authors:  Pankaj Sharma; Rikhia Chakraborty; Lu Wang; Booki Min; Michel L Tremblay; Tsukasa Kawahara; J David Lambeth; S Jaharul Haque
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.